Toward understanding the molecular basis for chemical allosteric modulator design.

[1]  David S. Wishart,et al.  DrugBank 3.0: a comprehensive resource for ‘Omics’ research on drugs , 2010, Nucleic Acids Res..

[2]  Geng Wu,et al.  ASD: a comprehensive database of allosteric proteins and modulators , 2010, Nucleic Acids Res..

[3]  S. Muresan,et al.  Investigation of the relationship between topology and selectivity for druglike molecules. , 2010, Journal of medicinal chemistry.

[4]  Yoshifumi Fukunishi,et al.  Development of Chemical Compound Libraries for In Silico Drug Screening. , 2010, Current computer-aided drug design.

[5]  Ian H. Witten,et al.  The WEKA data mining software: an update , 2009, SKDD.

[6]  N. Goodey,et al.  Allosteric regulation and catalysis emerge via a common route. , 2008, Nature chemical biology.

[7]  David S. Wishart,et al.  DrugBank: a knowledgebase for drugs, drug actions and drug targets , 2007, Nucleic Acids Res..

[8]  D. Fairlie,et al.  A new paradigm for protein kinase inhibition: blocking phosphorylation without directly targeting ATP binding. , 2007, Drug discovery today.

[9]  J. Lindsley,et al.  Whence cometh the allosterome? , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[10]  D. Wishart,et al.  DrugBank: a comprehensive resource for in silico drug discovery and exploration , 2005, Nucleic Acids Res..

[11]  Jian Zhang,et al.  Focused combinatorial library design based on structural diversity, druglikeness and binding affinity score. , 2005, Journal of combinatorial chemistry.

[12]  A. Villaverde.  Allosteric enzymes as biosensors for molecular diagnosis , 2003, FEBS letters.

[13]  P. Johnston,et al.  5-Fluorouracil: mechanisms of action and clinical strategies , 2003, Nature Reviews Cancer.

[14]  M. Beato,et al.  Control of Transcription by Steroid Hormones a , 1996, Annals of the New York Academy of Sciences.

[15]  R. Lamb,et al.  Ion channel activity of influenza A virus M2 protein: characterization of the amantadine block , 1993, Journal of virology.

[16]  Lawrence H. Pinto,et al.  Influenza virus M2 protein has ion channel activity , 1992, Cell.

[17]  J. Changeux,et al.  ON THE NATURE OF ALLOSTERIC TRANSITIONS: A PLAUSIBLE MODEL. , 1965, Journal of molecular biology.

[18]  J. Changeux,et al.  Allosteric proteins and cellular control systems. , 1963, Journal of molecular biology.

[19]  E. Sutherland,et al.  Inactivation and Activation of Liver Phosphorylase , 1955, Nature.

[20]  S. Colowick,et al.  THE ACTION OF NUCLEOTIDES IN THE DISRUPTIVE PHOSPHORYLATION OF GLYCOGEN , 1938 .

[21]  Arthur Christopoulos,et al.  Allosteric modulators of GPCRs: a novel approach for the treatment of CNS disorders , 2009, Nature Reviews Drug Discovery.

[22]  Miklos Feher,et al.  Property Distributions: Differences between Drugs, Natural Products, and Molecules from Combinatorial Chemistry , 2003, J. Chem. Inf. Comput. Sci..

[23]  E. Krebs,et al.  The phosphorylase b to a converting enzyme of rabbit skeletal muscle. , 1956, Biochimica et biophysica acta.